COMMUNIQUÉS West-GlobeNewswire

Adamis Pharmaceuticals Provides Update for Naloxone Product Candidate
03/09/2019
SAN DIEGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today the completion of pharmacokinetic (PK) studies comparing its naloxone injection product candidate, ZIMHI TM [...]
Abeona Therapeutics annonce un examen stratégique
03/09/2019
La société engage Jefferies LLC en réponse à un intérêt stratégique que celle-ci lui a manifesté NEW YORK et CLEVELAND, 03 sept. 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), leader entièrement [...]
Radius Health to Participate in the Citi 14th Annual Biotech Conference and Morgan Stanley 17th Annual Global Healthcare Conference in September
03/09/2019
WALTHAM, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) today announced its participation in the following conferences in September 2019. Radius Health management will host meetings with [...]
Abeona Therapeutics Announces Strategic Review
03/09/2019
Company engages Jefferies LLC in response to strategic inbound interest NEW YORK and CLEVELAND, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell [...]
Feng Lin, MD, Ph.D., Joins Therapeutic Solutions International as Chief Scientific Officer
03/09/2019
Immuno-Oncology Nutraceutical Company Positions Itself for Expansion into FDA OCEANSIDE, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., ( OTC Markets: TSOI ) [...]
Calithera Biosciences to Present New Data on Two Oncology Programs at ESMO Congress 2019
03/09/2019
-Results from ENTRATA Phase 2 trial of telaglenastat in patients with advanced renal cell carcinoma (RCC) accepted as Late Breaking Oral Presentation- -Data from INCB001158 clinical program accepted as Oral Presentation [...]
The European Society of Cardiology Includes Neovasc Reducer™ for the Treatment of Refractory Angina in the European Practice Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes
03/09/2019
Announcement Made at European Society of Cardiology Congress 2019 in Paris, France VANCOUVER, British Columbia, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader [...]
Golden Leaf Holdings Ltd. Appoints Jeffrey Yapp as New CEO
03/09/2019
Seasoned Marketer and Entrepreneur with Global Tech and Consumer Brand Experience Charged with Scaling Business into Key Markets TORONTO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: [...]
Allogene Therapeutics Announces September 2019 Investor Conference Schedule
03/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies [...]
Eyenovia to Present at Two Upcoming Investor Conferences
03/09/2019
NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]
Progenics Pharmaceuticals Announces Presentation at the International Conference on Immunotherapy Radiotherapy Combinations
03/09/2019
NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, today [...]
PDS Biotechnology to Present at the 21st Annual H.C. Wainwright Global Investment Conference
03/09/2019
BERKELEY HEIGHTS, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional [...]
Shockwave Receives FDA Breakthrough Device Designation for the Coronary IVL System
03/09/2019
Agency’s Breakthrough Device Designation Program Allows for Priority Review of Coronary Calcium Modification Technology SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc., a pioneer in the [...]
GeneTx and Ultragenyx Announce Orphan Drug Designation and Rare Pediatric Disease Designation for GTX-102
03/09/2019
SARASOTA, Fla. and NOVATO, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel [...]
Generex Biotechnology Confirms Record Date for 1:1 Dividend
03/09/2019
Record date of August 30, 2019 confirmed Shareholders must hold shares through October 30, 2019 to receive dividend Dividend Waived by insiders, note holders, acquisitions, and pool shares Pool shares being retired on [...]
Todos Medical Enters into MOU to Expand Existing Early Detection Breast Cancer Blood Test Distribution Partnership with Orot+ into Japan
03/09/2019
REHOVOT, Israel, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) , a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and [...]
Selecta Biosciences to Present at the Janney Healthcare Conference
03/09/2019
WATERTOWN, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune [...]
Cocrystal Pharma Presents Positive Preclinical Data for CC-42344 at the Options X for the Control of Influenza Conference
03/09/2019
- CC-42344 showed broad spectrum activity, excellent anti-influenza activity (EC50 <1 nM), and a strong synergistic effect with approved influenza antivirals - - Preclinical study demonstrated favorable [...]
TRACON Pharmaceuticals to Present at the Rodman & Renshaw 21st Annual Global Investment Conference Sponsored by H.C. Wainwright
03/09/2019
SAN DIEGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]

Pages